Radionuclide-Dependent Stimulation of Antitumor Immunity in GD2-Targeted Radiopharmaceutical Therapy Combined with Immune Checkpoint Inhibitors. - Lilieholm C; Zaborek J; Kwon O; Adeniyi AO; Kerr CP; Rojas HC; Idrissou MB; Ferreira CA; Clark PA; Jin WJ; Grudzinski JJ; Erbe AK; et al. (Radiation (Multidisciplinary Digital Publishing Institute), 2025)